DRW Securities, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 43 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DRW Securities, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$37
-56.5%
120,3650.0%0.00%
-50.0%
Q2 2023$85
-21.3%
120,3650.0%0.00%0.0%
Q1 2023$108
-23.9%
120,3650.0%0.00%
-50.0%
Q4 2022$142
-100.0%
120,3650.0%0.00%
-78.9%
Q2 2022$758,000
-24.1%
120,3650.0%0.02%
-29.6%
Q1 2022$999,000
+59.8%
120,3650.0%0.03%
+50.0%
Q4 2021$625,000
-22.3%
120,3650.0%0.02%
-48.6%
Q3 2021$804,000
-21.6%
120,3650.0%0.04%
+9.4%
Q2 2021$1,026,000
-3.7%
120,3650.0%0.03%
-23.8%
Q1 2021$1,065,000
-28.0%
120,3650.0%0.04%
-19.2%
Q4 2020$1,479,000
+20.8%
120,365
-20.0%
0.05%
-22.4%
Q3 2020$1,224,000
+15.5%
150,365
+36.2%
0.07%
+34.0%
Q2 2020$1,060,000
+41.3%
110,3650.0%0.05%
+78.6%
Q1 2020$750,000
-54.4%
110,3650.0%0.03%
-56.2%
Q4 2019$1,644,000
+45.4%
110,3650.0%0.06%
-16.9%
Q3 2019$1,131,000
+52.4%
110,365
+57.7%
0.08%
+87.8%
Q2 2019$742,000
+195.6%
70,000
+182.8%
0.04%
+215.4%
Q4 2018$251,000
+41.8%
24,752
+67.8%
0.01%
+30.0%
Q3 2018$177,000
-24.0%
14,752
-22.8%
0.01%
-28.6%
Q2 2018$233,000
+47.5%
19,100
+19.4%
0.01%
+40.0%
Q1 2018$158,00016,0000.01%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$6,144,0004.00%
P.A.W. CAPITAL CORP 380,000$3,363,0002.96%
INTERWEST VENTURE MANAGEMENT CO 764,918$6,770,0001.78%
Telemetry Investments, L.L.C. 150,477$1,332,0001.51%
683 Capital Management, LLC 2,683,600$23,750,0001.26%
KNOTT DAVID M 276,535$2,447,0001.05%
Trellus Management Company, LLC 226,000$2,000,0001.04%
TOWERVIEW LLC 140,000$1,239,0000.77%
Vivo Capital, LLC 1,791,257$15,853,0000.56%
CAXTON CORP 94,083$833,0000.54%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders